Home  /  Resource Library  /  Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma

Results of a study investigating dual CD19 and CD20 CAR T therapy for treatment of relapsed DLBCL.